CD8A and colorectal carcinoma: Here, we revealed that a CD8α hinge and transmembrane provides superior avidity, in vitro effector function, and in vivo antitumor efficacy targeting the CRC antigen GUCY2C in the context of a “3rd generation” 28BBζ CAR.